Studies in adolescent animals suggest that some components of the developing serotonergic system respond to SSRI treatment in a similar fashion to the adult system. For example, chronic (over 22 days) ...

Neuroscientists recently identified molecular mechanisms in the brain that may explain why the active ingredient (fluoxetine) in selective serotonin reuptake inhibitors (SSRIs) sold under brand names ...

Please provide your email address to receive an email when new articles are posted on . Antidepressants, particularly SSRIs like escitalopram, were tied to a faster cognitive decline. Higher dispensed ...

With the advent of new technology, comes a better understanding of the brain and the hope for novel treatments and medications with improved specificity and therapeutic efficacy. The most widely used ...